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In 2007, the Society for Cardiovascular Angiography and
Interventions (SCAI) published an Expert Consensus
Document titled “The Current Status and Future Direc-
tion of Percutaneous Coronary Intervention without On-
Site Surgical Backup” (1). This document summarized
the available data on the performance of percutaneous
coronary intervention (PCI) without on-site surgery in the
United States (US), reviewed the existing literature,
examined the recommendations for the performance of
PCI in this setting from several professional organizations
abroad and from experienced programs in the US, deﬁned
the best practices for facilities engaged in PCI without on-
site surgery and made recommendations for the future role
of PCI without on-site surgery.
Since publication of that document, new studies, meta-
analyses, and randomized trials have been published
comparing PCI with and without on-site surgery. In
addition, the total number of PCIs performed annually has
decreased, reports about the overuse of PCI have emerged,
and appropriate use criteria for coronary revascularization
have been published. A noteworthy change occurred in the
2011 PCI guideline in which elective PCI was upgraded to
Class IIb and primary PCI was upgraded to Class IIa atfacilities without on-site surgery (2). Several tables on the
structure and operation of programs without on-site sur-
gery from the 2007 SCAI Expert Consensus Document
were used in the 2011 PCI guideline recommendations.
Finally, new updates of the ACCF/SCAI Expert
Consensus Document on Cardiac Catheterization Labo-
ratory Standards and the ACCF/AHA/SCAI Clinical
Competence in Coronary Artery Interventional Procedures
have been published (3,4).
Although many of the concerns about the safety of PCI
without on-site surgery have been resolved, there are new
issues to consider as the delivery of PCI continues to evolve
in the US. Accordingly, the SCAI, ACCF, and AHA have
engaged in this effort to re-evaluate the current status of
PCI without on-site surgery in the US. The speciﬁc goals
of this effort were to:
1. Determine current trends in the prevalence of PCI
without on-site surgery in the US;
2. Summarize new literature related to the performance
of PCI without on-site surgery;
3. Review existing guidelines, expert consensus doc-
uments, competency statements and other docu-
ments related to PCI without on-site surgery and
summarize all relevant information into a single
resource document;N, Gardner TJ, Grines CL, Singh M. SCAI/ACC/AHA
nsus document: 2014 update on percutaneous coronary inter-
hout on-site surgical backup. J Am Coll Cardiol 2014;
e is copublished with Catheterization and Cardiovascular Interventions
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26254. Outline the current best practice methods and re-
quirements for facilities engaged in performing PCI
without on-site surgery; and
5. Evaluate the role of PCI without on-site surgery
within the current US healthcare system.Trends in the Performance of PCI
Although the use of PCI in the US had grown consider-
ably since the early 1980s, data from the Nationwide
Inpatient Sample cited by the Agency for Healthcare
Research and Quality shows that the annual volume of
PCI procedures peaked in 2006 and has since declined by
over 30% (5). Numerous factors have contributed to this
decline, including a reduction in restenosis by drug-eluting
stents, a greater emphasis on medical therapy for the
treatment of stable coronary artery disease, enhanced pri-
mary and secondary prevention efforts, a reduction in the
incidence of ST-segment elevation myocardial infarction
(STEMI), the increasing use of techniques such as frac-
tional ﬂow reserve to better evaluate lesion severity and
the development and application of appropriate use criteria
(5,6). As a result of these factors, many operators and
hospitals now have low-volume practices. Using data
from 2008, Maroney et al. estimated that 61% of inter-
ventional cardiologists performed 40 or fewer Medicare
fee-for-service PCIs annually (7). Clinical data from
1298 facilities reporting to the National Cardiovascular
Data Registry (NCDR) show that 49% of facilities
performed 400 PCIs and 26% performed 200 PCIs
annually (Fig. 1) (8). Approximately 33% of facilities had
no on-site surgery, and among these, 65% (282 facilities)
had an annual case volume of 200 PCI procedures.
Across the US, PCI without on-site surgery has
increased since 2007. The writing committee assessed theure 1. PCI Volume at Facilities With and Without
rdiac Surgery
roduced from Dehmer et al. (8) with permission.current use of PCI without on-site surgery from a survey
of ACC Governors for each state, data from industry
sources and direct contact with physicians in various
states (Fig. 2). Currently, 45 states allow both primary and
elective PCI without on-site surgery, 4 states allow only
primary PCI without on-site surgery, and 1 state prohibits
PCI without on-site surgery. PCI without on-site surgery
is regulated by the State Department of Health in 34
states but is unregulated in the remaining 16 states.
Elective PCI without on-site surgery was allowed at
selected facilities in 9 states but only as part of state-
wide demonstration projects or to allow participation in
the Cardiovascular Patient Outcomes Research Team
(CPORT) Nonprimary PCI (CPORT-E) trial (9). Since
the conclusion of CPORT-E, the use of PCI without on-site
surgery is being re-evaluated in several of these states. PCI
without on-site surgery is currently performed in 19 of the
65 cardiac catheterization laboratories within the Veterans
Health Administration (10).Recent Literature on PCI Without On-Site Surgery
Since 2006, 11 original studies and 3 meta-analyses on the
topic of PCI without on-site surgery have been identiﬁed
by a computerized systematic literature search using
Medline (PubMed and Ovid) and Cochrane Databases
(9,11–23).
Primary PCI without on-site surgery. Seven studies and
2 meta-analyses of primary PCI showed no difference for
in-hospital or 30-day mortality between sites with and
without on-site surgery (Table 1). None of the individual
studies examining the occurrence of emergency CABG
surgery after primary PCI showed a difference between
sites with and without on-site surgery. However, 1 meta-
analysis showed that sites without on-site surgery had a
lower occurrence of emergency CABG surgery afterFigure 2. Change in the Availability of PCI Without
On-Site Surgery From 2007 to 2013
The numbers shown indicate the number of states where primary and nonprimary PCI
without on-site surgery are allowed.
Table 1. Studies on Primary PCI Without On-Site Surgery Published Since 2006
Author (Year) Sites
On-Site
Surgery
No. of
Patients
in Arm
Mortality Emergency CABG
CommentsIncidence % OR (95% CI) Incidence % OR (95% CI)
Carlsson (2007)
(12)
Multicenter
SCAAR
No 857 7.0 1.05 (0.79–1.40) 0.1 30-day mortality is reported;
Incidence of emergency CABG
is for all patients (primary and
nonprimary PCI)
registry Yes 4,595 6.7 0.2
Peels (2007)
(13)
Single center No 336 2.1 2.17 (0.26–17.8) 0 0.10 (0.00–2.51)
Yes 103 0.97 1.0
Pereira (2008)
(14)
Multicenter
Portuguese
No 1,214 5.0 0.79 (0.55–1.14) 1.8 1.52 (0.90–2.56) Cardiogenic shock mortality was
53.4% with on-site surgery
and 50.9% without (NS)registry Yes 1,470 4.0 2.7
Kutcher (2009)
(15)
Multicenter
NCDR
No 1,934 5.1 0.97 (0.79–1.20) 0.7 0.60 (0.35–1.03) In-hospital mortality reported.
Only 42% of sites without
on-site surgery performed
36 primary PCIs annually
compared with 80% of sites
with on-site surgery
registry Yes 31,099 5.2 1.2
Pride (2009)
(16)
Multicenter
NRMI
No 1,795 3.3 0.86 (0.61–1.23) Propensity matched patient
cohort. In-hospital mortality
reported and only for patients
undergoing primary PCI.
Incidence of emergency CABG
not reported
database Yes 1,795 3.8
Hannan (2009)
(17)
Multicenter
New York
State
No 1,729 2.3 1.22 (0.76–1.94) 0.06 0.17 (0.02–1.38) Propensity matched patient
cohort. In-hospital/30-day
mortality reported
database Yes 1,729 1.9 0.35
Singh (2009)
(18)
3 sites No 667 2.5 0.80 (0.42–1.54) 0.7 1.25 (0.33–4.68) Propensity matched patient
cohort of nonelective PCI
deﬁned as acute MI within
24 h or cardiogenic shock.
Mayo Clinic
experience
Yes 667 3.1 0.6
Meta-analyses
Zia (2011)
(19)
No 8,703 6.1 0.93 (0.83–1.05) 3.0 0.87 (0.68–1.11) 9 studies included in the
analysisYes 97,386 7.6 3.4
Singh (2011)
(20)
No 16,489 4.6 0.96 (0.88–1.05) 0.22 0.53 (0.35–0.79) 11 studies included in the
analysisYes 107,585 7.2 1.03
CABG, coronary artery bypass graft surgery; NCDR, National Cardiovascular Data Registry; NRMI, National Registry of Myocardial Infarction; OR, odds ratio; PCI, percutaneous coronary
intervention; SCAAR, Swedish Coronary Angiography and Angioplasty Registry.
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0.35–0.79) (20).
PCI without on-site surgery for conditions other than
STEMI. Eight studies examined nonprimary PCI at
sites with and without on-site surgery (Table 2). The
majority of studies and meta-analyses showed no
difference in mortality or a need for emergency CABG
at sites without on-site surgery. One study at a high-
volume facility performing only elective PCIs and
staffed by high-volume interventionalists showed a
lower mortality at the facility without on-site surgery
(OR, 0.11; 95% CI 0.01–0.79) (21). However, the
baseline clinical and angiographic characteristics of
the study groups with and without on-site surgery
were sufﬁciently different that a meaningful adjusted
analysis could not be performed, and there is therefore
the possibility of a case selection bias.
Two randomized trials of nonprimary PCI have now
been published. The CPORT-E trial randomized over18,000 patients in a 1:3 ratio to undergo PCI at hos-
pitals with and without on-site cardiac surgery, respec-
tively (9). High-risk patients were excluded, as was the
use of atherectomy devices. The trial had 2 primary
endpoints: 6-week mortality and 9-month incidence
of major adverse cardiac events (composite of death, Q-
wave myocardial infarction, or target-vessel revasculari-
zation). The 6-week mortality rate was 0.9% at hospitals
without on-site surgery compared with 1.0% at those
with on-site surgery (p ¼ 0.004 for noninferiority). The
9-month rates of major adverse cardiac events were
11.2% and 12.1% at hospitals with and without on-site
surgery, respectively (p ¼ 0.05 for noninferiority). A
similar, but smaller randomized study of nonemergency
PCI was performed in Massachusetts hospitals (11).
The rates of major adverse cardiac events were 9.5% in
hospitals without on-site cardiac surgery and 9.4% in
hospitals with on-site cardiac surgery at 30 days (relative
risk, 1.00; 95% one-sided upper conﬁdence limit, 1.22;
p < 0.001 for noninferiority) and 17.3% and 17.8%,
Table 2. Studies on Nonprimary PCI Without On-Site Surgery Published Since 2006
Author (Year) Sites
On-Site
Surgery
No. of
Patients
in Arm
Mortality Emergency CABG
CommentsIncidence % OR (95% CI) Incidence % OR (95% CI)
Carlsson (2007)
(12)
Multicenter
SCAAR
No 7,981 0.81 1.23 (0.91–1.65) 0.1 30-day mortality is reported;
Incidence of emergency
CABG is for all patients
(primary and nonprimary
PCI)
registry Yes 20,930 0.66 0.2
Frutkin (2008)
(21)
2 sites No
Yes
1,090
3,317
0.09
0.8
0.11 (0.01–0.79) 0.2
0.03
6.10 (0.55–67.3) Nonrandomized comparison
of 2 sites. Stable and
unstable angina plus
NSTEMI included. In-hospital
mortality shown
Pereira (2008)
(14)
Multicenter
Portuguese
No 4831 0.5 1.43 (0.85–2.41) 0.7 3.14 (2.13–4.63)
registry Yes 5584 0.7 2.1
Kutcher (2009)
(15)
Multicenter
NCDR
No 6,802 0.8 0.99 (0.76–1.30) 0.2 0.69 (0.40–1.16) 72% of sites without on-site
surgery performed <200 PCIs
annually compared with 6%
among sites with on-site
surgery
registry Yes 268,312 0.8 0.3
Pride (2009)
(22)
Multicenter
NRMI
No 1,282 1.0 0.76 (0.37–1.58) Only patients with NSTEMI
included in study cohort
registry Yes 1,282 1.3
Singh (2009)
(18)
3 sites
Mayo clinic
No 1,842 0.2 0.57 (0.17–1.95) 0 1.00 (0.02–50.4) Propensity matched patient
cohort
experience Yes 1,842 0.4 0.2
Aversano (2012)
(9)
Multicenter
randomized
trial
No
Yes
14,149
4,718
0.9
1.0
0.1
0.2
Mortality reported after 6 weeks
and incidence of emergency
CABG shown.
Jacobs (2013)
(11)
Multicenter
randomized
trial
No
Yes
2,774
917
0.7
0.3
1.96 (0.58–6.64) 0.3
0.1
2.30 (0.3–18.6) All-cause and cardiac mortality
at 30 days were no different.
PCI without on-site surgery
was not inferior
Meta-analyses
Zia (2011) (19) No
Yes
28,552
881,261
1.6
2.1
1.03 (0.64–1.66) 1.0
0.9
1.38 (0.65–2.95) 6 studies included
in the analysis
Singh M
(2011) (20)
No
Yes
30,423
883,865
0.9
0.8
1.15 (0.93–1.41) 0.17
0.29
1.21 (0.52–2.85) 9 studies included
in the analysis
Singh PP
(2011) (23)
No
Yes
1,812
4,039
0.17
0.72
2.3 (0.60–12.97) 0.11
0.02
0.47 (0.07–3.19) 4 studies included
in the analysis but
only 2 with data on
mortality and CABG;
Risk ratios rather
than OR are reported
in this analysis
CABG, coronary artery bypass graft surgery; NCDR, National Cardiovascular Data Registry; NRMI, National Registry of Myocardial Infarction; OR, odds ratio; PCI, percutaneous coronary
intervention; SCAAR, Swedish Coronary Angiography and Angioplasty Registry.
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sided upper conﬁdence limit, 1.13; p < 0.001 for non-
inferiority). The individual rates of death, myocardial
infarction, repeat revascularization and stroke did not
differ signiﬁcantly between the groups at either time
point.
Three meta-analyses conducted primarily with registry
data have examined the use of nonprimary PCI at facil-
ities with and without on-site surgery (19,20,23). Over-
all, the mortality rate and need for emergency CABG
surgery did not differ between hospitals with andwithout on-site surgery. In 1 meta-analysis, after adjust-
ing for publication bias, the mortality rate for nonprimary
PCI was 25% higher at centers without on-site surgery
compared with centers that had on-site surgery (OR,
1.25; 95% CI, 1.01–1.53; p ¼ 0.04) (20). However, it is
important to note that these meta-analyses preceded the
publication of the 2 randomized trials (9,11). Therefore,
based on these recent studies, there is no indication of
increased mortality or a greater need for emergency
CABG for either primary or nonprimary PCI at sites
without on-site cardiac surgery.
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Policy Statements, and Other Programs
Since 2007, there have been several new documents pub-
lished that provide guidance for the performance of PCI
without on-site surgery. Each new document builds
incrementally upon the recommendations from prior
documents with slight modiﬁcations based on new infor-
mation. The recommendations for PCI programs without
on-site surgery are maturing and becoming uniform over
time through the vetting of these recommendations by
numerous separate writing committees and undergoing
extensive external reviews during document development.
Key recommendations for PCI without on-site surgery
from those documents are brieﬂy summarized below and
have been combined to develop the uniﬁed recommenda-
tions in this document.
2009 Focused Guideline Update on the
Management of Patients with STEMI
and Guideline Update on PCI
The 2009 focused update of the ACC/AHA guidelines for
the management of patients with STEMI and the ACC/
AHA/SCAI guidelines on PCI has been superseded by
newer separate guidelines for STEMI and PCI (2,24,25).
However, a number of the recommendations from the
2009 document regarding triage and transfer of patients
and the development of local STEMI systems have been
incorporated into the current document.
2011 ACCF/AHA/SCAI Guideline for
Percutaneous Coronary Intervention
Compared with prior guidelines, the 2011 ACCF/AHA/
SCAI Guideline for Percutaneous Coronary Intervention
stipulated new classiﬁcation ratings for both primary and
elective PCI at hospitals without on-site cardiac surgery
(2). Primary PCI was assigned a Class IIa recommendation
(Level of Evidence: B) stating that primary PCI is
“reasonable,” provided appropriate planning for program
development has been accomplished. Previously, this was
assigned a Class IIb recommendation. Elective PCI, pre-
viously assigned a Class III recommendation, was given a
Class IIb recommendation (Level of Evidence: B) stating it
“might be considered in hospitals without on-site cardiac
surgery, provided that appropriate planning for program
development has been accomplished and rigorous clinical
and angiographic criteria are used for proper patient se-
lection”. Elective PCI without on-site cardiac surgical
backup was considered appropriate only when performed
by experienced operators, with complication rates and
outcomes equivalent or superior to national benchmarks.
Importantly, the ACCF/AHA/SCAI PCI guidelines
state, “desires for personal or institutional ﬁnancial gain,
prestige, market share, or other similar motives are not
appropriate considerations for initiation of PCI programs
without on-site cardiac surgery.” The guideline assigns aClass III recommendation (Level of Evidence: C) to per-
forming primary or elective PCI in hospitals without
on-site cardiac surgery without a proven plan for rapid
transport to a cardiac surgery operating room in a nearby
hospital and without appropriate hemodynamic support
capability for transfers. The 2011 PCI guideline document
adapted personnel, facility, operator and structural re-
quirements for PCI without on-site surgery from the
2007 SCAI Expert Consensus document (1). New facility
and operator volume requirements were not addressed in
the 2011 PCI guidelines but deferred to the 2013 PCI
Clinical Competency document (4). In 2011, ACCF/
AHA also published a Guideline for Coronary Artery
Bypass Surgery that did not discuss the performance of
PCI without on-site surgery (26).
2012 ACCF/SCAI Expert Consensus Document on
Cardiac Catheterization Laboratory Standards
Update
Similar to the 2011 PCI guidelines, this document pre-
sented requirements for PCI at facilities without on-site
cardiac surgery that were derived from the 2007 SCAI
expert consensus document with some modiﬁcations (3).
This document also presented criteria for excluding pa-
tients, based on risk and lesion characteristics, from PCI
at facilities without on-site cardiac surgery. The document
prescribed the quality assurance/quality improvement
(QA/QI) program necessary for all cardiac catheterization
laboratories with speciﬁc recommendations for structure,
process, and outcome variables appropriate for monitoring.
Moreover, it recommended that all major complications
be reviewed by the QA/QI committee at least every 6
months and that any individual operator with complication
rates above benchmarks for 2 consecutive 6-month in-
tervals should have the issue directly addressed by the QA
director with a written plan for remediation. The docu-
ment also recommended that a random sample of cases
from all operators should be reviewed at least annually.
2013 ACCF/AHA/SCAI Update of the
Clinical Competence Statement on
Coronary Artery Interventional Procedures
In addition to deﬁning numerous requirements for oper-
ator competency, new operator, and facility PCI volume
requirements were established (4). Reﬂecting the overall
decline in PCI volumes, this document recommended
that laboratories performing both primary and elective
PCI, with and without on-site cardiac surgery, should
perform a minimum of 200 PCIs annually. Laboratories
performing <200 cases annually must have stringent
systems and process protocols in place with close moni-
toring of clinical outcomes and additional strategies that
promote adequate operator and catheterization laboratory
staff experience through collaborative relationships with
larger volume facilities. The existence of laboratories
performing <200 PCIs annually that are not serving
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2629isolated or underserved populations should be questioned,
and any laboratory that cannot maintain satisfactory
outcomes should be closed. This recommendation was
based on an extensive review of studies that identiﬁed
a signal suggesting worse outcomes in laboratories
performing <200 PCIs annually. The writing committee
recommended that operators perform a minimum of 50
PCIs annually (averaged over 2 years), including no less
than 11 primary PCIs annually. Ideally, these procedures
should be performed in institutions performing >200 total
and >36 primary PCI procedures annually. However, it
was emphasized that individual operator volume is but one
of several factors that should be considered in assessing
operator competence, which include lifetime experience,
institutional volume, the operator’s other cardiovascular
interventions and quality assessment of the operator’s
ongoing performance. Operators who cannot maintain
these case volume recommendations at their primary
practice site should maintain privileges and continue to
perform PCI procedures at a high-volume institution with
on-site surgical backup to meet annual volume re-
quirements. It was also recommended that operators
should be board certiﬁed in interventional cardiology and
maintain certiﬁcation, with the exception of operators who
have received equivalent training outside the US and are
ineligible for board certiﬁcation in the US.
2013 ACCF/AHA Guideline for the Management
of ST-Elevation Myocardial Infarction
This document did not speciﬁcally comment on PCI
without on-site cardiac surgery but supported the 2011
ACCF/AHA/SCAI PCI guidelines recommendations
(25). It recommended that primary PCI be performed in
high-volume, well-equipped centers with experienced
interventional cardiologists, and skilled support staff.
2010 European Society of Cardiology and
European Association for Cardio-Thoracic Surgery
Guidelines
In contrast to the 2011 ACC/AHA/SCAI PCI guidelines,
the 2010 European Society of Cardiology and the Euro-
pean Association for Cardio-Thoracic Surgery guidelines
on myocardial revascularization do not comment on PCI
without on-site surgery or issues related to institutional or
operator competency (27). However, the European
guidelines continue to stress the importance of full
disclosure regarding the lack of availability of on-site car-
diac surgery and the inadvisability of performing PCI for
high-risk patients/lesions at facilities that do not have on-
site surgical backup.
The European guidelines for STEMI do not provide
speciﬁc recommendations regarding PCI at centers
without on-site surgery (28). Rather, emphasis is placed on
the development of networks between hospitals with
differing levels of technology, connected by an efﬁcient
emergency transport system. To maximize staff experience,the guidelines recommend that primary PCI centers
perform procedures 24 h a day, 7 days a week for all
STEMI patients.
Other models mentioned in the European guidelines,
although not ideal, include weekly or daily rotation of
primary PCI centers or multiple primary PCI centers in
the same region. Hospitals that cannot offer a 24/7 service
for primary PCI should be allowed to perform primary
PCI in patients already admitted for another reason and
who develop STEMI during their hospital stay. These
hospitals should, however, be discouraged from initiating
a service limited to daytime or within-hours primary PCI,
because this generates confusion with Emergency Medical
Services (EMS) operators and is unlikely to match the
door-to-balloon time and quality of intervention of focused
24/7 primary PCI centers. In a survey of European
countries, the mean population served by a single primary
PCI center varied between 0.3 and 7.4 million inhabitants.
In countries offering primary PCI services to the majority
of their STEMI patients, this population varied between
0.3 and 1.1 million per center (29). In small service areas,
experience can be suboptimal due to an insufﬁcient
number of STEMI patients, but the optimal size of a
catchment area could not be clearly deﬁned. For
geographical areas where the expected transfer time to a
primary PCI center makes it impossible to achieve satis-
factory reperfusion times, thrombolysis with subsequent
immediate transfer to a primary PCI center has been
endorsed. Although there is a risk of intracranial bleeding,
a potential role for this strategy in selected circumstances
has been emphasized (30).
Other Guidelines and Recommendations
The 2007 SCAI Expert Consensus Document summa-
rized the recommendations from the British Cardiac So-
ciety and British Cardiovascular Intervention Society, the
Cardiac Society of Australia and New Zealand (CSANZ),
the Spanish Society of Cardiology, the Brazilian Society of
Hemodynamics and Interventional Cardiology (Sociedade
Brasileira de Hemodinamica e Cardiologia Intervencionista)
and from several other countries (31–39). Since 2007, only
the guidelines from CSANZ have been updated, most
recently in 2011 (32). CSANZ guidelines state that pri-
mary PCI without on-site surgery should be performed: (a)
by operators and institutions meeting the overall re-
quirements and standards of primary PCI centers; (b) by
institutions with a proven plan for rapid transport to a
cardiac surgical center; (c) in a timely fashion (<90 min);
and (d) using rigorous case selection criteria. The CSANZ
guidelines acknowledged that rural patients might have
limited access to diagnostic angiography and PCI, and
providing these services at institutions without on-site
surgery by appropriately trained individuals facilitates eq-
uity of access, which should result in improved quality of
care. However, the CSANZ guidelines also speciﬁcally
state that rural and regional centers should not perform
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than 1 hour travel time from cardiac surgery centers.
AHA Policy Statement on PCI Without
Surgical Backup
In March 2012, the AHA issued a policy statement on
PCI without surgical backup deﬁning two major reasons
for providing PCI without on-site surgery (40). First,
PCI without on-site surgery is considered reasonable
if the intent is to provide high quality timely primary
PCI for patients with STEMI. The statement recom-
mended that each community and facility in the com-
munity have an agreed-upon plan for how STEMI
patients are to be treated. The plan should indicate
hospitals that should receive STEMI patients from
EMS units capable of obtaining diagnostic electrocar-
diograms, the management at the initial receiving hos-
pital and written criteria and agreements for the
expeditious transfer of patients from nonPCI-capable to
PCI-capable facilities. Second, PCI without on-site sur-
gery is a reasonable consideration for providing local care to
patients and families who do not want to travel signiﬁcant
distances or who have certain preferred local physicians.
This is an important consideration, but the policy statement
emphasized that evolving evidence suggests that such cen-
ters should have mechanisms in place to ensure high quality
care. In addition to emphasizing the current guideline
classiﬁcations for PCI without on-site surgery, the AHA
policy statement provided recommendations for states
wishing to address the issue of PCI without on-site surgery
through the regulation of legislation.
Mission Lifeline
The Mission Lifeline program developed in 2006 from a
series of conferences sponsored by the AHA and has
continued to mature (41–43). The goal of Mission Lifeline
is to improve the quality of care and outcomes for patients
with STEMI and to improve healthcare system readiness
and response to STEMI. An important focus of Mission
Lifeline is to increase the number of patients with timely
access to primary PCI. Criteria for the structure and
operation of a STEMI referral and STEMI-receiving
hospitals are part of the Mission Lifeline initiative and
apply to facilities without on-site surgery.
Door-to-Balloon Alliance
The Door-to-Balloon (D2B) effort began in January
2006 when the ACC recognized the need to reduce D2B
times for patients with STEMI. This led to the develop-
ment of a national initiative to achieve D2B times 90
min for at least 75% of nontransfer primary PCI patients
with STEMI in participating hospitals performing primary
PCI. This alliance consists of a nationwide network of
hospitals, physician champions and strategic partners
committed to improving D2B times. Participation in the
Alliance provides the necessary tools; information andsupport for helping hospitals achieve the D2B treatment
goals and encourages the use of real-time performance
feedback on D2B times to drive the quality improvement
effort (44). The D2B program has been highly successful,
having achieved its initial goals (45).
Access to Primary PCI in the United States
Data from the American Hospital Association and the
2000 US Census were used to estimate the proportion
of the adult population (18 years of age) who lived
within 60 min of a PCI hospital (46). An estimated 79.0%
lived within a 1 hour drive of a PCI hospital, with a
median driving time of 11.3 min. Even among those living
closer to non-PCI hospitals, 74% would experience <30
min of additional delay with a direct referral to a PCI
hospital. Approximately 5 years later, Concannon et al.,
using similar data sources and methodology, showed that
despite a 44% relative increase in the number of facilities
capable of performing PCI, the number of adults within a
1 hour drive of a PCI facility increased to only 79.9%, with
the median driving time reduced by <1 min to 10.5 min
(47). Access in rural areas remained far less than in urban
areas, with driving times reduced for only 9% of the
population compared with the earlier survey. These ﬁnd-
ings mirrored a smaller experience in Michigan where
expansion of primary PCI to 12 hospitals without on-site
surgery increased access for only 4.8% of the population
(48). Finally, Horwitz et al. showed that hospitals are
more likely to introduce new invasive cardiac services when
neighboring hospitals already offer such services and
conﬁrmed that the increase in the number of hospitals
offering invasive cardiac services has not led to a corre-
sponding increase in geographic access (49). In total, these
data support the argument that the addition of more PCI
centers has not substantially improved access to PCI ser-
vices for most patients.
Financial Considerations for Facilities Providing
PCI Without On-site Surgery
Medicare payments to hospitals for invasive cardiac
procedures have generally remained favorable, although
physician reimbursement has decreased. Per-case revenue
margins for PCI are typically higher than the overall
hospital operating margins, and PCI improves the hos-
pital case mix index. PCI programs bring prestige to an
institution, and STEMI is one of the most prestigious
diseases for treatment (50,51). The push to develop rapid
STEMI care has led many to currently advocate for EMS
bypassing non-PCI hospitals; there is even consideration
being given to triaging patients based on D2B metrics.
Exclusion from providing STEMI care might be a lesser
ﬁnancial concern than the loss of downstream revenue
from additional testing in patients suspected of having an
acute coronary syndrome. This includes not only testing
performed to exclude CAD as the cause of chest pain but
also testing to evaluate noncardiac causes of chest pain.
Table 3. Facility Requirements for PCI Programs Without On-Site Surgery
General Recommendations Source
Requisite support equipment must be available and in good working order to respond to emergency situations. PCI-GL
PCI-CS
ML
Should demonstrate appropriate planning for program development and should complete both a primary PCI development program and an
elective PCI development program. Program developments to include routine care process and case selection review.
AHA
D2B
Full support from hospital administration in fulﬁlling the necessary institutional requirements, including appropriate support services such as
intensive care, advanced imaging (CT, MR and other vascular imaging), respiratory care, blood bank and nephrology consultation with access to
dialysis.
PCI-GL,
PCI-CS
ECD
The institution should have systems for credentialing and governing the PCI program. On-site data collection, quality assessment, quality
improvement and error management are essential. Each institution must establish an ongoing mechanism for valid and continuous peer review
of its quality and outcomes. A quality improvement program should routinely 1) review quality and outcomes of the entire program; 2) review
results of individual operators; 3) include risk adjustment; 4) provide peer review of difﬁcult or complicated cases; and 5) perform random case
reviews. The review process should assess the appropriateness of the interventional procedures. Evaluation should include the clinical
indications for the procedure, technical performance and the quality and interpretation of the coronary angiograms.
PCI-CS, AHA,
PCI-GL
ECD
Written agreements for emergency transfer of patients to a facility with cardiac surgery must exist. Transport protocols should be tested a
minimum of 2 times per year involving both the referring and receiving facility. Develop agreements with a ground or air ambulance service
capable of advanced life support and IABP transfer that guarantees a transport vehicle will be on-site to begin transport in 30 min and arrival
at the surgical hospital within 60 min of the decision to declare the need for emergency surgery. Tertiary facility must agree to accept emergent
and nonemergent transfers for additional medical care, cardiac surgery or intervention. Tertiary centers should be able to establish
cardiopulmonary bypass on emergency transfer patients within <120 min of an urgent referral.
PCI-GL, AHA
PCI-CS
ECD
New
Well-equipped and maintained cardiac catheterization laboratory with high-resolution digital imaging capability. The capability for real-time
transfer of images and hemodynamic data (via T-1 transmission line) as well as audio and video images to review terminals for consultation at
the facility providing surgical backup support is highly recommended.
PCI-GL
PCI-CS
ML
Appropriate inventory of interventional equipment, including guide catheters, balloons and stents in multiple sizes; thrombectomy and distal
protection devices; covered stents; temporary pacemakers; and pericardiocentesis trays. Access to other diagnostic modalities such as
intravascular ultrasound and fractional ﬂow reserve is required. Rotational or other atherectomy devices and the treatment of CTOs should not
be performed in facilities without on-site surgery.
PCI-GL,
PCI-CS
New
Meticulous clinical and angiographic selection criteria for PCI (Table 5). PCI-GL, AHA
Participation in a national data registry, such as the ACC NCDR in the United States is required. This allows benchmarking, risk adjustment and
facilitates outcomes analysis of local data.
PCI-GL
ECD
AHA
A program should be in place to track and ensure treatments with ACC/AHA guideline-based Class I therapies, both acutely and at discharge. PCI-CS,
ML
Full service laboratories (both primary and elective PCI, with and without on-site cardiac surgery) performing <200 cases annually must have
stringent systems and process protocols with close monitoring of clinical outcomes and additional strategies that promote adequate operator
and catheterization laboratory staff experience through collaborative relationships with larger volume facilities. Both physicians and staff should
have the opportunity to work at a high volume center to enhance their skills. The continued operation of laboratories performing <200
procedures annually that are not serving isolated or underserved populations should be questioned and any laboratory that cannot maintain
satisfactory outcomes should be closed.
PCI-CS
Geographic isolation exists if the emergency transport time to another facility is >30 min. New
Satisfactory outcomes should be deﬁned by each local facility as part of their quality review process and should be based on national or regional
benchmarks. Programs that fail to meet their established criteria for satisfactory performance for 2 consecutive quarters must undertake
efforts to improve engaging outside experts if necessary. Failure to improve quality metrics should also be grounds for program closure
regardless of the location.
ML
PCI-CS
D2B
As part of the local continuous quality improvement program, there should be a regular review of all patients transferred for emergency surgery
with the outcome of surgery and identiﬁcation of improvement opportunities.
PCI-GL
Continued on the next page
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2631This can be an additional ﬁnancial motivator for devel-
oping PCI facilities (52). How the further bundling of
payments and reimbursements on a global or capitated
basis by accountable care organizations (ACO) will affect
PCI programs is unclear at this time, but given the
concerns about the cost of healthcare, increases in pay-
ments are unlikely (53,54). However, even in an ACO
environment, hospitals might beneﬁt from keeping car-
diovascular procedures in-house where they have the
ability to control costs rather than transferring patients to
tertiary hospitals.The Volume-Outcome Relationship for PCI
and the Certiﬁcate of Need
There are 26 states with Certiﬁcate of Need (CON) reg-
ulations for the development of cardiac catheterization
laboratories, but the effect of such regulations is uncertain.
Ho et al. found that the removal of state cardiac CON
regulations was associated with an increase in the number
of hospitals performing CABG and PCI, but the state-
wide number of procedures was unchanged. The average
procedure volume per hospital for both CABG and PCI
therefore declined (55). Despite this, they found no
Table 3. Continued
STEMI Treatment Recommendations
Each community should develop a STEMI system of care that follows standards at least as strong as those developed for Mission Lifeline,
including:
 Performance of primary PCI as the ﬁrst-choice treatment for STEMI to ensure streamlined care paths and increased case volumes.
 A process for prehospital identiﬁcation and activation.
 Protocols for triage, diagnosis and cardiac catheterization laboratory activation should be established within the primary PCI hospital/STEMI-
Receiving Center.
 A single activation phone call should alert the STEMI team. Criteria for EMS activation of the cardiac catheterization laboratory should be
established in conjunction with EMS providers.
 Transfer protocols for patients who arrive at STEMI referral centers who are in cardiogenic shock and/or are primary PCI candidates ineligible
for ﬁbrinolytic drugs.
2009
PCI-GL
2011
PCI-GL
ML
D2B
STEMI receiving centers should be available and on-call 24 hours/7 days a week (no diversion) to perform primary PCI. Primary PCI should not be
performed at facilities unless it is provided on a 24/7 schedule.a The cardiac catheterization laboratory staff and interventional cardiologist
should arrive within 30 min of a STEMI activation call. Facilities should have a plan for triage and treatment of simultaneous presentation of
STEMI patients.
PCI-GL,
AHA
ML
STEMI receiving centers should perform a minimum of 36 primary PCI procedures annually, and these procedures should ideally be performed at
facilities that perform a minimum of 200 total PCI procedures annually.
PCI-GL
PCI-CS
ML
Facilities performing only primary PCI should perform a minimum of 36 primary PCIs annually and work in collaboration with a high volume PCI
facility to ensure good outcomes
PCI-GL
PCI-CS
There should be a recognized STEMI-Receiving Center liaison/system coordinator to the system and a recognized physician champion. ML
The STEMI-Receiving Centers should participate in the Mission Lifeline-approved data collection tool, ACTION Registry-Get with the Guidelines. ML
D2B
They should also participate in the regional Mission Lifeline Stakeholder group (if available) to contribute to the development of a regional STEMI
System of Care Plan
ML
Monthly multidisciplinary team meetings to evaluate outcomes and quality improvement data. Operational issues should be reviewed, problems
identiﬁed, and solutions implemented. The following measurements should be evaluated on an ongoing basis:
a. Door-to-ﬁrst device time, nontransfer patients
b. STEMI Referral Hospital ED door-to-balloon (ﬁrst device used) time
c. First medical contact to balloon inﬂation (ﬁrst device used) time, nontransfer patients
d. First medical contact to balloon inﬂation (ﬁrst device used) time, transfer patients
e. Proportion of eligible patients receiving reperfusion therapy
f. Proportion of eligible patients administered guideline-based class I therapies
g. Proportion of patients with ﬁeld diagnosis of STEMI and activation of the Cardiac Catheterization Laboratory for intended primary PCI who
i. do not undergo acute catheterization because of misdiagnosis
ii. undergo acute catheterization and found to have no elevation in cardiac biomarkers and no revascularization in the ﬁrst 24 h
h. In-hospital mortality
ML
Italics font: New or modiﬁed recommendation in the document.
aRequired for U.S. facilities but might not be possible for all facilities worldwide.
ACC, American College of Cardiology; AHA, American Heart Association policy statement; CT, computed tomography; CTO, chronic total occlusion; D2B, Door-to-Balloon Alliance; ECD, 2012
Expert Consensus Document on Cardiac Catheterization Standards; EMS, emergency medical systems; GL, Guidelines; IABP, intra-aortic balloon pump; IVUS, intravascular ultrasound;
ML, Mission Lifeline; MR, magnetic resonance; New, New recommendation in this document; NCDR, National Cardiovascular Data Registry; PCI-CS, 2013 PCI Competency Statement; PCI-GL,
2011 ACCF/AHA/SCAI PCI guidelines; PCI, percutaneous coronary intervention; SCAI, Society for Cardiovascular Angiography and Interventions; and STEMI, ST-segment elevation myocardial
infarction.
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2632evidence that CON regulations lowered procedural mor-
tality rates for CABG or PCI. In other studies, CON
regulation of cardiac catheterization was associated with
care that was judged more appropriate, whereas the
removal of CON regulation of cardiac surgery has been
associated with an increase in low-volume cardiac surgical
centers and increased mortality (56,57). Concerns have
been raised that the proliferation of small centers per-
forming complex procedures that have a small but deﬁnite
risk of important complications might dilute the ability to
provide efﬁcient high quality service (52,58). Reduced
mortality has been associated with an increased volume of
primary PCI procedures in centers, higher volume opera-
tors, total volume of PCIs in centers, and the commitment
of a center to provide PCI rather than ﬁbrinolytic therapy
(59–63). Lieu et al. reported that redundant or low-volumeprimary PCI programs were cost ineffective (64). Elective
PCI at centers without on-site surgery was more expensive
than PCI at centers with on-site surgery in one case-
matched study (65). In addition, the high ﬁxed costs of a
cardiac surgery program in the face of decreasing surgical
volumes is leading to the consolidation of numerous smaller
surgery programs, depriving some PCI programs of surgical
backup.
The issue of a PCI volume-outcome relationship was
extensively reviewed in the 2013 PCI Competency docu-
ment for centers with and without on-site surgery and for
primary and elective PCI (4). The document concluded
that in the current era, volume-outcome relationships are
not as robust as in the past when balloon angioplasty was
the only treatment modality. However, an institutional
volume threshold of <200 PCIs annually appeared to be
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2633consistently associated with worse outcomes. Primary PCI
volume  the guideline-recommended minimum of 36
annually was associated with worse in-hospital mortality
in a recent series of over 86,000 patients in the NCDR
(66). The cutoff points of <200 total PCIs annually
and 36 primary PCIs annually has important implica-
tions because 26% of the PCI facilities submitting data to
the NCDR performed 200 total PCIs annually and 38%
performed 36 primary PCIs annually (8,66). Recent data
suggested a modest volume-outcome relationship for var-
iables other than mortality, but these data have limitations
and are not consistent across all studies (4). Although there
was an association between annual PCI volumes <200 and
worse outcomes, there was no association between higher
annual hospital volumes and improved outcomes at higher
volume PCI centers. There was less evidence to support a
threshold for individual operator volume for both elective
and primary PCI.
Recommendations
We have provided recommendations for PCI without
on-site surgery that are a composite of recommen-
dations from the 2007 SCAI Expert Consensus Statement,
the 2011 PCI guidelines, the 2012 Expert Con-
sensus Document on Cardiac Catheterization Laboratory
Standards, the 2013 PCI Competency statement and rec-
ommendations from the policy statement of the American
Heart Association and requirements for the Mission Life-
line program and D2B Alliance (1–4,40,43,44). Redundant
recommendations from these documents were consoli-
dated, and the writing committee included several
new recommendations consistent with evolving practice
standards.Table 4. Personnel Requirements for PCI Programs Without On-Site
Personnel Recommendations
Experienced nursing and technical laboratory staff with training in interventional labo
patients with hemodynamic and electrical instability.
Coronary care unit nursing staff must be experienced and comfortable with invasive
management of IABP, management of in-dwelling arterial/venous sheaths and iden
ischemia and access site complications.
Personnel should be capable of endotracheal intubation and ventilator management
Operators should have ABIM board certiﬁcation in interventional cardiology and mainta
through equivalent training outside the United States and are ineligible for ABIM c
Interventional cardiologists should perform a minimum of 50 coronary interventional p
competency.
Primary PCI should be performed by experienced operators who perform a minimum
primary PCI procedures per year. Ideally, these procedures should be performed in
and more than 36 primary PCI procedures for STEMI per year.
Facilities should develop internal review processes to assess operators performing <
several factors that should be considered in assessing operator competence, whic
operator’s other cardiovascular interventions and quality assessment of the operat
It is unwise for a newly trained interventional cardiologist to start a new PCI program. N
PCI program should be mentored by existing physicians until it is determined their
Italics font: New or modiﬁed recommendation in the document.
ABIM, American Board of Internal Medicine; ML, Mission Lifeline; PCI-CS, 2013 PCI Competency Sta
new recommendation in this document; PCI, percutaneous coronary intervention; STEMI, ST-segmeFacility Requirements for PCI Programs
Without On-Site Surgery
Facility requirements are similar to those presented in past
documents but now include a greater emphasis on the
presence of quality review programs for facilities and op-
erators, as described in the 2013 PCI competency docu-
ment (4) (Table 3). Diagnostic modalities such as IVUS
and especially fractional ﬂow reserve previously considered
desirable for facilities without on-site surgery have now
increased in importance and are necessary for all PCI
centers.
The 2013 PCI Competency Document identiﬁed a
signal suggesting that an institutional volume threshold
of <200 PCIs/year was associated with worse outcomes.
Therefore, the 2013 Competency Document recom-
mended that the continued operation of laboratories
performing <200 procedures annually that are not
serving isolated or underserved populations be ques-
tioned and that any laboratory that cannot maintain
satisfactory outcomes should be closed. Past documents
have not speciﬁed any criteria for geographic isolation.
The writing committee suggests it be deﬁned not by
distance but by the time required for emergency transport
of a STEMI patient to another facility. Hospitals justify
the creation of new PCI centers without on-site surgery
by stating that they improve access for geographically
under-served populations and allow patients to be cared
for in close geographic proximity to their own families
and physicians. However, multiple low-volume and
partial-service PCI centers within a geographic area
diffuse PCI expertise, increase costs for the overall health
system and have not been shown to improve access
(46–49). If the transfer time is 30 min, it is reasonableSurgery
Source
ratories. Personnel must be comfortable treating acutely ill PCI GL
PCI-CS
hemodynamic monitoring, operation of temporary pacemaker,
tifying potential complications such as abrupt closure, recurrent
PCI-GL
PCI-CS
New
both on-site and during transfer if necessary. PCI-GL
in certiﬁcation, with the exception of operators who have gone
ertiﬁcation and recertiﬁcation exams.
PCI CS
rocedures per year (averaged over a 2-year period) to maintain PCI-CS
of 50 elective PCI procedures per year and, ideally, at least 11
institutions that perform more than 200 elective PCIs per year
PCI-CS
ML
50 PCIs annually. Individual operator level volume is one of
h include lifetime experience, institutional volume, individual
or’s ongoing performance.
PCI-CS
ewly trained interventional cardiologists joining an established
skills, judgment and outcomes are acceptable.
New
tement; PCI-GL, 2011 ACCF/AHA/SCAI PCI guidelines; IABP, intra-aortic balloon pump; New,
nt elevation myocardial infarction.
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2634to assume that transfer to the nearest PCI center will
provide reperfusion as rapidly as if it were available at the
ﬁrst hospital. For transport times longer than 30 min,
performing PCI on-site is likely to be quicker than a
transfer. The development of PCI facilities within a
30-min emergency transfer time to an established facility
is therefore strongly discouraged.
What constitutes a reasonable transport time for a pa-
tient requiring emergency surgery has not been consis-
tently addressed in prior documents. Both CPORT-E
and MASS-COMM studies provide guidance contained
in their on-line supplementary materials (9,11). Both
require a transport vehicle to be available to begin
transport within 30 min and arrival at the surgicalTable 5. Recommendations for Off-Site Surgical Backup and Case S
RecommendationsdCardiologist–Cardiac Surgeon Interactions
Interventional cardiologists must establish a working relationship with cardiac surgeo
Cardiac surgeons should have privileges at the referring facility to allow review of tre
Ideally, face-to-face meetings between cardiothoracic surgeons and cardiologists invo
especially for the discussion of management of patients undergoing nonprimary PC
involvement of the LAD or comorbidities such as diabetes, depressed LV function
Cardiac surgeon and receiving hospital agree to provide cardiac surgical backup for urg
hours.
Surgeon and receiving facility ensure that patients will be accepted based on medical
request and availability of resources. If this cannot be ensured before the start of a
Interventional cardiologists must review with surgeons the immediate needs and stat
Interventional cardiologist should be familiar with and have immediate access to appr
and should be qualiﬁed for handling emergencies such as pericardial tamponade
Hospital administrations from both facilities endorse the transfer agreement.
Transferring physicians obtain consent for surgery from patients or appropriate surrog
Initial informed consent for PCI discloses that the procedure is being performed witho
risks related to transfer. The consent process should include the risk of urgent surge
PCI should be obtained before the procedure and before any sedatives are given. C
informed consent and is unacceptable in non-emergency situations.
RecommendationsdCase Selection and Management
Avoid intervention in patients with:
>50% diameter stenosis of left main artery proximal to infarct-related lesion, esp
function is not severely impaired.
 Long, calciﬁed, or severely angulated target lesions at high risk for PCI failure with
 Lesions in areas other than the infarct artery (unless they appeared to be ﬂow li
symptoms).
 Lesions with TIMI ﬂow grade 3 in patients with left main or three-vessel disease wh
compared with PCI.
 Culprit lesions in more distal branches that jeopardize only a modest amount of m
worsened by attempted intervention.
 Chronic total occlusion.
The management of patients with STEMI resuscitated from sudden cardiac death is co
without therapeutic hypothermia or possible transfer to a tertiary facility for trea
Emergency transfer for coronary bypass surgery patients with
 High-grade left main or three-vessel coronary disease with clinical or hemodynam
vessel and preferably with IABP support.
 Failed or unstable PCI result and ongoing ischemia, with IABP support during tra
Italics font: New or modiﬁed recommendation in the document.
CTO, chronic total occlusion; ECD, 2012 Expert Consensus Document on Cardiac Catheterization
LV, left ventricle; New, new recommendation in this document; PCI, percutaneous coronary intervehospital within 60 min of the decision to declare the
need for emergency surgery. MASS-COMM further
recommends that surgical intervention begin within 120
min. Given the existing data on the distribution of PCI
facilities in the US, the performance of elective PCI
at facilities that cannot meet these transfer times is
discouraged (46,47).
The 2013 PCI competency document also states that
any laboratory that cannot maintain satisfactory outcomes
should be closed; however, there is currently no national
deﬁnition for “satisfactory outcomes”. The writing com-
mittee recommends that these be deﬁned by each PCI
center, including those with on-site surgery, as part of
their quality review process, using national benchmarkelection
Source
ns at the receiving facility. PCI-GL
ECD
atment options as time allows. PCI-GL
ECD
lved should occur on a regular basis (Heart Team approach)
I who have left main, three-vessel CAD or two-vessel CAD with
or complex anatomy.
PCI-GL
ECD
New
ent cases at all hours and for elective cases at mutually agreed PCI-GL
ECD
condition, capacity of surgeon to provide services at the time of
n elective procedure, the case should not be done at that time.
PCI-GL
ECD
us of any patient transferred for urgent surgery. PCI-GL
ECD
opriate life support devices, such an intraaortic balloon pumps,
and embolization.
PCI-GL
ECD
PCI-GL
ECD
ates. PCI-GL
ECD
ut on-site surgical backup and acknowledges the possibility of
ry and state that a written plan for transfer exists. Consent for
onsent for PCI obtained while the patient is on the table is not
PCI-GL
ECD
New
ecially if the area in jeopardy is relatively small and overall LV
TIMI ﬂow grade 3 present during initial diagnostic angiography.
miting in patients with hemodynamic instability or ongoing
ere bypass surgery is likely a superior revascularization strategy
yocardium when there is more proximal disease that could be
mplex, and decisions about the need for immediate PCI with or
tment should be individualized.
PCI-GL
ECD
New
ic instability after successful or unsuccessful PCI of an occluded
nsfer.
PCI-GL
ECD
Standards; PCI-GL, 2011 ACCF/AHA/SCAI PCI Guidelines; IABP, intraaortic balloon pump;
ntion; TIMI, thrombolysis in myocardial infarction.
Table 6. Patient and Lesion Characteristics That Could Be Unsuitable for Nonemergency Procedures at Facilities Without
On-Site Cardiac Surgery
High-risk patients Source
 Decompensated congestive heart failure (Killip Class 3) without evidence for active ischemia.
 Recent (<8 weeks) cerebrovascular accident.
 Advanced malignancy.
 Known clotting disorders.
 LVEF 30%.
 Chronic kidney disease (creatinine >2.0 mg/dL or creatinine clearance <60 mL/min).
 Serious ongoing ventricular arrhythmias.
 Patients with left main stenosis (>50% diameter) or three-vessel disease unprotected by prior bypass surgery (>70% stenoses in the proximal or
mid segments of all major epicardial coronary arteries), treatment of any or all stenoses. Scoring systems, such as SYNTAX, may be useful in
deﬁning the extent of disease and type of revascularization procedure.
 Patients with a single-target lesion that jeopardizes an extensive amount of myocardium.
 Patients undergoing intervention on the last remaining conduit to the heart.
PCI-GL
AHA
ECD
High-risk lesions
 Unprotected left main stenosis.
 Diffuse disease (>20 mm in length).
 Extremely angulated segment (>90%) or excessive proximal or in-lesion tortuosity.
More than moderate calciﬁcation of a stenosis or proximal segment
 Inability to protect major side branches.
 Degenerated older vein grafts with friable lesions.
 Substantial thrombus in the vessel or at the lesion site.
 Any other feature that could, in the operator’s judgment, impede successful stent deployment.
 Anticipated need for rotational or other atherectomy device, cutting balloon or laser.
PCI-GL
ECD
New
The characteristics listed above identify high-risk patient and lesion features but are not absolute contraindications to performing PCI at a facility
without on-site surgery. For example, an elevated creatinine level increases the procedure risk for the patient, but this is not unique to facilities
without on-site surgery and treatments to mitigate this complication can be used at all facilities. Ultimately, the operator should consider all factors
and make a decision about the suitability of the patient for PCI at the facility.
New
Strategy for surgical backup based on lesion and patient risk
 High-risk patients with high-risk lesions should not undergo nonemergency PCI at a facility without on-site surgery.
 High-risk patients with nonhigh-risk lesions: Nonemergency patients with this proﬁle may undergo PCI, but conﬁrmation that a cardiac surgeon
and operating room are immediately available is necessary.
 Non-high-risk patients with high-risk lesions require no additional precautions.
 Non-high-risk patients with nonhigh-risk lesions require no additional precautions. Best scenario for PCI without on-site surgery.
PCI-GL
Italics font: New or modiﬁed recommendation in the document.
CTO, chronic total occlusion; ECD, 2012 Expert Consensus Document on Cardiac Catheterization Standards; PCI-GL, 2011 ACCF/AHA/SCAI PCI Guidelines; LVEF, left ventricular ejection
fraction; New, new recommendation; PCI, percutaneous coronary intervention; SYNTAX, Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery.
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2635data. Programs failing to meet established criteria for
satisfactory performance for two consecutive quarters
must undertake efforts to improve their performance,
engaging outside experts if necessary. Failure to improve
quality metrics should lead to program closure regardless
of the location. To ensure proper assessment and moni-
toring, laboratories are required to submit data to a na-
tional data registry, have regular meetings to discuss key
performance metrics and develop plans for the correction
of any deﬁciencies. Especially with facility PCI volumes
decreasing, it becomes increasingly difﬁcult to determine
whether there are signiﬁcant differences in the data re-
ports from year to year. For example, to detect (with
statistical certainty) a doubling of in-hospital mortality
from 1% to 2% at a hospital with an annual case volume of
200 PCIs, nearly 4 years of continuous data collection
would be required. This does not negate the importance
of data submission to a national registry that can help
identify trends, but it emphasizes why these same data
must be carefully evaluated and adjudicated at the local
facility. The importance of unbiased local or external peerreview cannot be overemphasized (67,68). Implementa-
tion of the SCAI Quality Toolkit and certiﬁcation by
Accreditation for Cardiovascular Excellence (ACE) are
recommended as resources for improving quality (69,70).
Personnel Requirements for PCI Programs
Without On-Site Surgery
Recognizing the potential for isolation and the advantage
of clinical experience, the 2007 SCAI Expert Consensus
Document included a recommendation that operators at
PCI programs without on-site surgery perform at least 100
total and 18 primary PCIs annually, a recommendation
that might not be achievable in the current environment.
The 2013 PCI Competency Document moves away from
strict volume requirements to focus more on achieving
quality metrics for facilities and individual operators. As
noted earlier, the 2013 Competency document recom-
mended that operators perform a minimum of 50 PCIs
annually (averaged over 2 years), including no less than
11 primary PCIs annually. Ideally, these procedures
should be performed in institutions performing >200
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2636total and >36 primary PCI procedures annually
(Table 4). Again acknowledging the importance of
experience, the 2007 SCAI Expert Consensus Document
suggested that initial operators at a new program without
on-site surgery should have a lifetime experience of >500
PCIs as primary operator after completing a fellowship.
In the current environment of decreasing PCI volumes
and in view of the recommendations of the 2013 PCI
competence document, this number would be difﬁcult
to achieve. Nevertheless, it is unwise for a newly trained
interventional cardiologist to start a new PCI program.
Newly trained interventional cardiologists joining an
established PCI program should be mentored by more
experienced physicians until it is determined that the
skills, judgment and outcomes of these new cardiologists
are acceptable.
Requirements for Off-Site Surgical Backup
Recommendations for the interactions between cardiolo-
gists and cardiac surgeons are listed in Table 5. A limita-
tion of programs performing PCI without on-site surgery
is the lack of on-site access to a cardiac surgeon for
consultation about revascularization options. This makes
the concept of a Heart Team consultation more difﬁcult to
achieve and could necessitate performing only diagnostic
catheterization until a case review with a cardiac surgeon
can be performed. The application of telemedicine con-
sultations with a heart surgeon could facilitate these in-
teractions. In reality, many of the nonemergency patients
who merit discussion by a Heart Team are not optimal
candidates for PCI at facilities without on-site cardiac
surgery. It is important to emphasize that the role of the
cardiac surgeon is not conﬁned to the treatment of PCI
complications but includes the participation in decisions
about revascularization options. Recommendations for
case selection at facilities without on-site surgery are shown
in Table 5, and criteria for identifying high-risk lesions and
patients are contained in Table 6. There are statistical
models for identifying PCI patients at higher risk for
mortality or emergency CABG that could be helpful for
identifying patients who should not undergo PCI at fa-
cilities without on-site surgery (18,71). However, these
models have not been tested or applied on a large scale to
determine the advisability of performing a PCI at facilities
without on-site surgery.
The Delivery of PCI Services in the Future
As a result of the additional randomized studies on PCI
without on-site surgery and the recent change in guideline
recommendations, the performance of PCI without on-site
surgery in the US has gained greater acceptance, and
questions about its safety in the presence of a proven, well
deﬁned, and protocol driven approach have diminished.
PCI programs should be evaluated based on their ability to:
(a) sustain adequate quality metrics, (b) provide access to
elective and emergency PCI procedures that wouldotherwise be unavailable in their service area, and (c)
maintain the operator and institutional volumes recom-
mended in the 2013 PCI Competency Document. For the
future, the focus must now shift to developing a rational
plan for the distribution of PCI services. Small PCI pro-
grams with large ﬁxed costs are inefﬁcient and unnecessary
if they do not improve access in areas of need. However, it
is unlikely that issues of system-wide efﬁciency will be
addressed without central planning on the state or federal
level. This writing group reafﬁrms the statement from the
2011 ACCF/AHA/SCAI PCI Guidelines that “desires for
personal or institutional ﬁnancial gain, prestige, market
share, or other similar motives are not appropriate con-
siderations for initiation of PCI programs without on-site
cardiac surgery” and suggests that new programs offering
PCI without on-site surgery are inappropriate unless they
clearly serve geographically isolated populations. The
writing group recognizes the need for ongoing study and
surveillance of all PCI programs through participation in
national databases encourages public reporting of their
results and acknowledges that further declines in PCI
volumes might necessitate the closure of PCI programs in
the future.REFERENCES
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According to the ACCF/AHA, a person has a relevant relationship IF: a) The relationship or interest relates to the same or similar subject matter, intellectual property or asset, topic, or issue
addressed in the document; or b) The company/entity (with whom the relationship exists) makes a drug, drug class, or device addressed in the document, or makes a competing drug or device
addressed in the document; or c) The person or a member of the person’s household, has a reasonable potential for ﬁnancial, professional or other personal gain or loss as a result of the issues/
content addressed in the document.
*Signiﬁcant relationship.
yNo ﬁnancial beneﬁt.
ACCF indicates American College of Cardiology; AHA, American Heart Association; CABG, Coronary Artery Bypass Graft Surgery; CIP, Coronary Interventional Procedures; PCI, Percutaneous
Coronary Intervention; SCAI, Society of Cardiovascular Angiography & Interventions.
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